VX-993
VX-993 is a pharmaceutical drug with 9 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 8 completed trials
Phase Distribution
Phase Distribution
7
Early Stage
2
Mid Stage
0
Late Stage
Highest Phase Reached
Phase 2Trial Status & Enrollment
100.0%
8 of 8 finished
0.0%
0 ended early
1
trials recruiting
9
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Evaluation of Efficacy and Safety of VX-993 for Pain Associated With Diabetic Peripheral Neuropathy
A Study Evaluating Efficacy and Safety of VX-993 for Acute Pain After a Bunionectomy
A Microneurography Study of NaV1.8 Inhibition in Healthy Adults
A Phase 1 Dose Escalation Study of Intravenous VX-993 in Healthy Adults
Evaluation of the Pharmacokinetic Drug-drug Interactions Between VX-993 and Metformin in Healthy Adults
Clinical Trials (9)
Evaluation of Efficacy and Safety of VX-993 for Pain Associated With Diabetic Peripheral Neuropathy
A Study Evaluating Efficacy and Safety of VX-993 for Acute Pain After a Bunionectomy
A Microneurography Study of NaV1.8 Inhibition in Healthy Adults
A Phase 1 Dose Escalation Study of Intravenous VX-993 in Healthy Adults
Evaluation of the Pharmacokinetic Drug-drug Interactions Between VX-993 and Metformin in Healthy Adults
A Study to Evaluate the Relative Bioavailability and Food Effect of a New Tablet Formulation of VX-993
A Phase 1, Open-label Study Evaluating the Pharmacokinetics and Drug-drug Interaction of VX-993 in Healthy Adults
A Phase 1 Study Evaluating the Safety, Pharmacokinetics, and Pharmacodynamics, of VX-993
A Phase 1 Dose Escalation Study of VX-993 in Healthy Participants
All 9 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 9